AlerisLife Inc. (ALR)

NEWTON, Mass.--(BUSINESS WIRE)--Diversified Healthcare Trust (Nasdaq: DHC) (“DHC”) today reiterated that, as part of the previously disclosed wind-down of AlerisLife Inc. (“AlerisLife”), the management agreements for 116 of DHC's senior housing operating portfolio (“SHOP”) communities are being sold and the operations transferred. Seven different managers, with established records of senior living operations will take over the 116 communities. The seven operators assuming the AlerisLife SHOP co.

NEWTON, Mass.--(BUSINESS WIRE)--AlerisLife Inc. and its senior living operating division, Five Star Senior Living, have been awarded with a Great Place to Work certification.

NEWTON, Mass.--(BUSINESS WIRE)--AlerisLife Inc. (Nasdaq: ALR) today announced that ABP Acquisition LLC, or ABP, has successfully completed the previously announced tender offer to acquire all outstanding shares of the common stock of ALR for $1.31 per share in cash. $1.31 per share represents an 85% premium to the 30-day average trading price prior to the tender announcement. The tender offer expired at one minute after 11:59 p.m., Eastern Time, on March 17, 2023. As of the expiration, 22,375,687 shares had been validly tendered and not validly withdrawn from the tender offer, representing approximately 72.8% of the outstanding shares of ALR common stock, including the 1,972,783 shares already owned by ABP. ABP subsequently accepted all 22,375,687 shares for payment. Following the closing of the tender offer, ALR merged with and into a subsidiary of ABP and all shares that had not been validly tendered were converted into the right to receive the same $1.31 per share in cash. As a result of the merger, ALR became a wholly owned subsidiary of ABP. Shares of ALR common stock ceased trading on Nasdaq and ABP intends to promptly cause such shares to be delisted. Payment will be made promptly to all former ALR stockholders regardless of whether they tendered their shares. About AlerisLife AlerisLife enriches and inspires the lives of its older adult customers across the United States by delivering an exceptional and enhanced resident experience to senior living and active adult residents, while also offering lifestyle services to the younger “choice-based” consumer. The Company is headquartered in Newton, Massachusetts. For more information, visit www.alerislife.com.

NEWTON, Mass.--(BUSINESS WIRE)--AlerisLife Inc. (Nasdaq: ALR) today announced that ABP Acquisition LLC, or ABP, has successfully completed the previously announced tender offer to acquire all outstanding shares of the common stock of ALR for $1.31 per share in cash. $1.31 per share represents an 85% premium to the 30-day average trading price prior to the tender announcement. The tender offer expired at one minute after 11:59 p.m., Eastern Time, on March 17, 2023.

For Healthcare REITs - the physical epicenter of the pandemic - the road to recovery has remained inconsistent across its distinct sub-sectors, with "private-pay" segments now showing notable improvement while "public-pay" segments relapse. Public-pay segments - Hospital and Skilled-Nursing - have seen a re-intensification of tenant operator issues amid pressure from soaring labor costs and waning government fiscal support, triggering some missed rents and lease renegotiations.

U.S. equity markets rebounded following their worst week of the year as investors parsed data showing surprising resilience in global economic activity this winter despite stiff interest rate headwinds. Snapping a three-week skid and notching its best week since late January, the S&P 500 advanced 2.0% this week, while the tech-heavy Nasdaq 100 rallied nearly 3%.

NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of AlerisLife Inc. (NasdaqCM: ALR) to ABP Acquisition LLC. Under the terms of the proposed transaction, shareholders of AlerisLife will receive $1.31 in cash for each share of AlerisLife that they own.

NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of AlerisLife Inc. (NasdaqCM: ALR) to ABP Acquisition LLC. Under the terms of the proposed transaction, shareholders of AlerisLife will receive $1.31 in cash for each share of AlerisLife that they own. KSF is seeking to determine whether this consideration and the process that led to it are adequate, or whether the consideration undervalues the Company. If you believe that this transaction undervalues the Company and/or if you would like to discuss your legal rights regarding the proposed sale, you may, without obligation or cost to you, e-mail or call KSF Managing Partner Lewis S. Kahn (lewis.kahn@ksfcounsel.com) toll free at any time at 855-768-1857, or visit https://www.ksfcounsel.com/cases/nasdaqcm-alr/ to learn more. Please note that the merger is structured as a tender offer, such that time may be of the essence. To learn more about KSF, whose partners include the Former Louisiana Attorney General, visit www.ksfcounsel.com.

NEW YORK--(BUSINESS WIRE)--Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC is investigating whether the Board of Directors of AlerisLife Inc. ("AlerisLife" or the "Company") (NASDAQ: ALR) breached their fiduciary duties in connection with the proposed sale of the Company to ABP Acquisition LLC (“ABP”). Under the terms of the agreement, the Company's shareholders will receive $1.31 in cash for each share of AlerisLife common stock owned. AlerisLife investors are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: www.bgandg.com/alr. The investigation concerns whether: (i) AlerisLife's board of directors acted in the best interests of Company shareholders in agreeing to the proposed transaction, (ii) the $1.31 per share merger consideration adequately compensates AlerisLife's shareholders, and (iii) all information regarding the sales process and valuation of the transaction will be fully and fairly disclosed. Notably, at least one analyst set a price target for the Company of $1.50 per share, $0.19 above the per-share merger consideration. If you own shares of AlerisLife and would like to learn more about this investigation, you can visit the firm’s site: www.bgandg.com/alr. You can also contact Peretz Bronstein or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC: 212-697-6484. Bronstein, Gewirtz & Grossman, LLC represents investors in securities fraud class actions and shareholder derivative suits. The firm has recovered hundreds of millions of dollars for investors nationwide. Attorney advertising. Prior results do not guarantee similar outcomes.

NEW YORK--(BUSINESS WIRE)---- $ALR #classaction--Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC is investigating whether the Board of Directors of AlerisLife Inc. ("AlerisLife" or the "Company") (NASDAQ: ALR) breached their fiduciary duties in connection with the proposed sale of the Company to ABP Acquisition LLC (“ABP”). Under the terms of the agreement, the Company's shareholders will receive $1.31 in cash for each share of AlerisLife common stock owned.

NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of AlerisLife Inc. (NasdaqCM: ALR) to ABP Acquisition LLC. Under the terms of the proposed transaction, shareholders of AlerisLife will receive $1.31 in cash for each share of AlerisLife that they own. KSF is seeking to determine whether this consideration and the process that led to it are adequate, or whether the consideration undervalues the Company. If you believe that this transaction undervalues the Company and/or if you would like to discuss your legal rights regarding the proposed sale, you may, without obligation or cost to you, e-mail or call KSF Managing Partner Lewis S. Kahn (lewis.kahn@ksfcounsel.com) toll free at any time at 855-768-1857, or visit https://www.ksfcounsel.com/cases/nasdaqcm-alr/ to learn more. Please note that the merger is structured as a tender offer, such that time may be of the essence. To learn more about KSF, whose partners include the Former Louisiana Attorney General, visit www.ksfcounsel.com.

NEW YORK , Feb. 6, 2023 /PRNewswire/ -- Weiss Law is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of AlerisLife Inc. ("AlerisLife" or the "Company") (NASDAQ: ALR) in connection with the proposed acquisition of the Company by ABP Acquisition LLC via tender offer. Under the terms of the merger agreement, the Company's shareholders will receive $1.31 in cash for each share of AlerisLife common stock owned.

NEW YORK , Feb. 3, 2023 /PRNewswire/ -- Juan Monteverde , founder and managing partner of the class action firm Monteverde & Associates PC (the "M&A Class Action Firm"), a national securities firm rated Top 50 in the 2018-2021 ISS Securities Class Action Services Report and headquartered at the Empire State Building in New York City, is investigating AlerisLife Inc. (NASDAQ: ALR), relating to its proposed sale to APB Acquisition LLC. Under the terms of the agreement, ALR shareholders are expected to receive $1.31 in cash per share they own.

MILWAUKEE , Feb. 3, 2023 /PRNewswire/ -- Ademi LLP is investigating AlerisLife (Nasdaq: ALR) for possible breaches of fiduciary duty and other violations of law in its transaction with ABP. Click here to learn how to join the action https://www.ademilaw.com/case/AlerisLife-technical-consultants-inc or call Guri Ademi toll-free at 866-264-3995.

Wilmington, Delaware--(Newsfile Corp. - February 3, 2023) - Rigrodsky Law, P.A. is investigating AlerisLife Inc. ("AlerisLife") (NASDAQ: ALR) regarding possible breaches of fiduciary duties and other violations of law related to AlerisLife's agreement to be acquired by ABP Acquisition LLC. Under the terms of the agreement, AlerisLife's shareholders will receive $1.31 per share in cash.To learn more about this investigation and your rights, visit: https://www.rl-legal.com/cases-alerislife-inc.To contact Seth D. Rigrodsky or Gina M.